Biochemical and cellular functions of Karyopherins
Biochemical and cellular functions of Karyopherins
批准号:
10626755
负责人:
Yuh Min Chook
金额:
$43.42万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-06-11 至 2026-05-31
关键词:
AffectApoptosisBase SequenceBindingBiochemicalCell physiologyConsensusCytoplasmDiseaseExportinsHealthHistone H2AHistonesHumanImportinsKaryopherinsLaboratoriesMalignant NeoplasmsMapsMediatingMolecular ChaperonesMutationNuclearNuclear ExportNuclear ImportNucleosomesOncogenicPhosphorylationProteinsRNA-Binding ProteinsSaccharomyces cerevisiaeSignal TransductionSpecificityStructureSystemcancer cellcomparativedesignimprovedinhibitormRNA Exportnucleocytoplasmic transportpreventresponsesmall molecule inhibitortransportin SR
中文摘要
Chook实验室的目标是了解核转运蛋白识别
结合伙伴和映射伙伴/货物库。我们的目标是了解核质
运输,其他karyopherin功能,并发现他们如何组织和调节细胞功能,
健康和疾病。20例同源人和14例S.酿酒酵母Kaps介导大多数核
运输我们对Karyopherin-β2进行了广泛的研究。我们发现PY-NLS
认识到,这一信号的物理组织特征,并设计了第一个核进口
抑制剂.核转运蛋白-β2和其他充分表征的输入蛋白,输入蛋白-β 2/β,输入蛋白-5和
转运蛋白-SR具有不同的特异性并结合完全不同的NLS类型。但剩下的
Importin:Importin-4,Importin-7,Importin-8,Importin-9和Importin-11,研究不足,
已知货物货物的稀缺性阻碍了它们的比较生物化学/结构定义
NLS。我们的目标是发现新的货物和NLS类研究不足的进口和映射
交通控制。我们发现,除了进口货物,进口也作为伴侣,
防止RNA结合蛋白聚集或作为组蛋白伴侣防止组蛋白H2 A-H2 B
聚集并协助核小体组装。我们将讨论Kap-2分子伴侣的机制
功能,以及Kap 114如何在典型组蛋白存在下导入和伴侣蛋白H2 A-H2 B
监护人在研究核出口方面,我们对了解
CRM 1如何结合NES和小分子抑制剂,但CRM 1的
在许多细胞过程和疾病状态中的重要性。CRM 1抑制剂Selinexor导致细胞凋亡
癌细胞,但目前还不知道哪些货物是针对不同的癌症。大多数>1000
含有NES的CRM 1货物未知。准确的内斯预测可以帮助识别新的货物,
但不同的内斯序列和模糊的共识,描述了在大多数螺旋中普遍存在的序列,
含有蛋白质的蛋白质使得基于序列的内斯预测效率低下。为了改善预测,我们
开发基于结构和能量的内斯预测器。我们还将研究CRM 1是如何在
对抑制剂的反应,了解CRM 1的致癌E571 K突变如何影响NES结合
和CRM 1介导的交通,并研究CRM 1介导的mRNA输出。最后,我们将扩大我们的研究
输出蛋白Msn 5,其结合多个细胞的内在无序和磷酸化片段,
货物,因此一个很好的系统来定义一个新的内斯类。
英文摘要
The Chook Laboratory aims to understand mechanisms of how Karyopherin- proteins recognize
binding partners and map partner/cargo repertoires. We aim to understand nuclear-cytoplasmic
transport, other karyopherin functions, and discover how they organize and regulate cellular functions, in
health and in disease. 20 homologous human and 14 S. cerevisiae Kaps mediate the majority of nuclear
transport. We have studied the importin Karyopherin-β2 extensively. We discovered the PY-NLS that it
recognizes, characterized the physical organization of this signal and designed the first nuclear import
inhibitor. Karyopherin-β2 and other well-characterized importins, Importin-/β, Importin-5 and
Transportin-SR, have distinct specificities and bind entirely different NLS types. However, the remaining
importins: Importin-4, Importin-7, Importin-8, Importin-9 and Importin-11, are under-studied with few
known cargos. Scarcity of cargos has prevented comparative biochemical/structural definition of their
NLSs. We aim to discover new cargos and classes of NLSs for understudied importins and map the
traffic they control. We showed that in addition to importing cargos, importins also act as chaperones to
prevent aggregation of RNA-binding proteins or act as histone chaperone to prevent histone H2A-H2B
aggregation and assist in nucleosome assembly. We will address the mechanism of Kap2 chaperone
functions, and how Kap114 imports and chaperones H2A-H2B in the presence of canonical histone
chaperones. In the study of nuclear export, we have contributed significantly to the understanding of
how CRM1 binds NESs and small molecule inhibitors, but there are many more questions given CRM1’s
importance in many cellular processes and disease states. CRM1 inhibitor Selinexor causes apoptosis
of cancer cells, but it is not known which cargos are targeted in different cancers. Most of the >1000
NES-containing CRM1 cargos are not known. Accurate NES prediction could help identify new cargos,
but diverse NES sequences and vague consensus that describes sequences ubiquitous in most helix-
containing proteins make sequence-based NES prediction inefficient. To improve prediction, we are
developing a structure- and energy-based NES predictor. We will also study how CRM1 is degraded in
response to inhibitors, understand how the oncogenic E571K mutation of CRM1 affects NES-binding
and CRM1-mediated traffic, and study CRM1-mediated mRNA export. Finally, we will expand our study
to the exportin Msn5, which binds intrinsically disordered and phosphorylated segments of multiple
cargos, hence an excellent system to define a new NES class.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
A new Karyopherin-β2 binding PY-NLS epitope of HNRNPH2 is linked to neurodevelopmental disorders.
HNRNPH2 的新核传递蛋白-β2 结合 PY-NLS 表位与神经发育障碍有关。
DOI:
10.1101/2023.01.20.524964
发表时间:
2023
期刊:
bioRxiv : the preprint server for biology
影响因子:
--
作者:
[Gonzalez,Abner, Kim,HongJoo, Freibaum,BrianD, JoyceFung,HoYee, Brautigam,ChadA, Taylor,JPaul, Chook,YuhMin]
通讯作者:
Chook,YuhMin
Biochemical and cellular functions of Karyopherins
-
批准号:10427212
-
项目类别:
-
资助金额:$43.42万
-
财政年份:2021
-
负责人:Yuh Min Chook
-
依托单位:
Biochemical and cellular functions of Karyopherins - Revision - 1
-
批准号:10555037
-
项目类别:
-
资助金额:$2.34万
-
财政年份:2021
-
负责人:Yuh Min Chook
-
依托单位:
Biochemical and cellular functions of Karyopherins
-
批准号:10190554
-
项目类别:
-
资助金额:$48.39万
-
财政年份:2021
-
负责人:Yuh Min Chook
-
依托单位:
Molecular Biophysics Training Program
-
批准号:10421305
-
项目类别:
-
资助金额:$24.11万
-
财政年份:2019
-
负责人:Yuh Min Chook
-
依托单位:
Molecular Biophysics Training Program
-
批准号:10180985
-
项目类别:
-
资助金额:$22.15万
-
财政年份:2019
-
负责人:Yuh Min Chook
-
依托单位:
Molecular Biophysics Training Program
-
批准号:10669042
-
项目类别:
-
资助金额:$24.16万
-
财政年份:2019
-
负责人:Yuh Min Chook
-
依托单位:
Splicing and Nuclear Transport of Influenza Virus mRNA
-
批准号:9278114
-
项目类别:
-
资助金额:$51.79万
-
财政年份:2016
-
负责人:Yuh Min Chook
-
依托单位:
Splicing and Nuclear Transport of Influenza Virus mRNA
-
批准号:9913442
-
项目类别:
-
资助金额:$51.79万
-
财政年份:2016
-
负责人:Yuh Min Chook
-
依托单位:
Structures and mechanisms of nuclear import and export
-
批准号:8795191
-
项目类别:
-
资助金额:$33.35万
-
财政年份:2004
-
负责人:Yuh Min Chook
-
依托单位:
Structures and mechanisms of nuclear import and export
-
批准号:7344817
-
项目类别:
-
资助金额:$26.09万
-
财政年份:2004
-
负责人:Yuh Min Chook
-
依托单位:
Structures and mechanisms of nuclear import and export
-
批准号:8603242
-
项目类别:
-
资助金额:$33.35万
-
财政年份:2004
-
负责人:Yuh Min Chook
-
依托单位:
Structures and mechanisms of nuclear import and export
-
批准号:7176055
-
项目类别:
-
资助金额:$28.62万
-
财政年份:2004
-
负责人:Yuh Min Chook
-
依托单位:
Structures and mechanisms of nuclear import and export
-
批准号:8440064
-
项目类别:
-
资助金额:$33.35万
-
财政年份:2004
-
负责人:Yuh Min Chook
-
依托单位:
Structures and mechanisms of nuclear import and export
-
批准号:7012851
-
项目类别:
-
资助金额:$26.87万
-
财政年份:2004
-
负责人:Yuh Min Chook
-
依托单位:
Structures and mechanisms of nuclear import and export
-
批准号:6718038
-
项目类别:
-
资助金额:$31.93万
-
财政年份:2004
-
负责人:Yuh Min Chook
-
依托单位:
Structures and mechanisms of nuclear import and export
-
批准号:7583830
-
项目类别:
-
资助金额:$31.4万
-
财政年份:2004
-
负责人:Yuh Min Chook
-
依托单位:
Structures and mechanisms of nuclear import and export
-
批准号:6846018
-
项目类别:
-
资助金额:$27.52万
-
财政年份:2004
-
负责人:Yuh Min Chook
-
依托单位:
Structures and mechanisms of nuclear import and export
-
批准号:8029543
-
项目类别:
-
资助金额:$30.78万
-
财政年份:2004
-
负责人:Yuh Min Chook
-
依托单位:
Structures and mechanisms of nuclear import and export
-
批准号:7196222
-
项目类别:
-
资助金额:$4.72万
-
财政年份:2004
-
负责人:Yuh Min Chook
-
依托单位:
Structures and mechanisms of nuclear import and export
-
批准号:8995206
-
项目类别:
-
资助金额:$33.35万
-
财政年份:2004
-
负责人:Yuh Min Chook
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: